Differential antigen presentation regulates the changing patterns of CD8+ T cell immunodominance in primary and secondary influenza virus infections

Journal of Experimental Medicine

Volumn 198, Issue 3, 2003, Pages 399-410

  Crowe, Sherry R ^a   Turner, Stephen J ^b   Miller, Shannon C ^a   Roberts, Alan D ^a   Rappolo, Rachel A ^a   Doherty, Peter C ^b   Ely, Kenneth H ^a   Woodland, David L ^a  

^a TRUDEAU INSTITUTE   (United States)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Antigen presentation; Antigen presenting cells; CD8 positive T lymphocytes; Immunologic memory; Influenza

Indexed keywords

CD8 ANTIGEN; EPITOPE;

ACUTE PHASE RESPONSE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ANTIGEN SPECIFICITY; ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; IMMUNOLOGICAL MEMORY; INFLUENZA; LYMPHOCYTE ACTIVATION; MEMORY CELL; MOUSE; NONHUMAN; PRIMARY IMMUNE RESPONSE; PRIORITY JOURNAL; SECONDARY IMMUNE RESPONSE; VACCINATION;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, VIRAL; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE; DENDRITIC CELLS; EPITOPES; FEMALE; IMMUNODOMINANT EPITOPES; IMMUNOLOGIC MEMORY; MICE; MICE, INBRED C57BL; ORTHOMYXOVIRIDAE; ORTHOMYXOVIRIDAE INFECTIONS; PEPTIDE FRAGMENTS; VIRAL CORE PROTEINS;

EID: 0043076183     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20022151     Document Type: Article

References (49)

1. Doherty, P.C., and R.M. Zinkernagel. 1976. Specific immune lysis of paramyxovirus-infected cells by H-2-compatible thymus-derived lymphocytes. Immunology. 31:27-32.
2. Kast, W.M., L. Roux, J. Curren, H.J. Blom, A.C. Voordouw, R.H. Meloen, D. Kolakofsky, and C.J. Melief. 1991. Protection against lethal Sendai virus infection by in vivo priming of virus-specific cytotoxic T lymphocytes with a free synthetic peptide. Proc. Natl. Acad. Sci. USA. 88:2283-2287.
3. Cole, G.A., T.L. Hogg, and D.L. Woodland. 1994. The MHC class I-restricted T cell response to Sendai virus infection in C57BL/6 mice: a single immunodominant epitope elicits an extremely diverse repertoire of T cells. Int. Immunol. 6:1767-1775.
4. Yewdell, J.W., and J.R. Bennink. 1999. Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses. Annu. Rev. Immunol. 17:51-88.
5. Chen, W., L.C. Anton, J.R. Bennink, and J.W. Yewdell. 2000. Dissecting the multifactorial causes of immunodominance in class I-restricted T cell responses to viruses. Immunity. 12:83-93.
6. Eisenlohr, L.C., J.W. Yewdell, and J.R. Bennink. 1992. Flanking sequences influence the presentation of an endogenously synthesized peptide to cytotoxic T lymphocytes. J. Exp. Med. 175:481-487.
7. Yewdell, J.W., and J.R. Bennink. 1992. Cell biology of antigen processing and presentation to major histocompatibility complex class I molecule-restricted T lymphocytes. Adv. Immunol. 52:1-123.
8. Bergmann, C.C., L. Tong, R. Cua, J. Sensintaffar, and S. Stohlman. 1994. Differential effects of flanking residues on presentation of epitopes from chimeric peptides. J. Virol. 68:5306-5310.
9. + T-cell responses to influenza virus. J. Virol. 76:10332-10337.
10. Belz, G.T., P.G. Stevenson, and P.C. Doherty. 2000. Contemporary analysis of MHC-related immunodominance hierarchies in the CD8+ T cell response to influenza A viruses. J. Immunol. 165:2404-2409.
11. Mullbacher, A., M. Lobigs, J.W. Yewdell, J.R. Bennink, R. Tha Hla, and R.V. Blanden. 1999. High peptide affinity for MHC class I does not correlate with immunodominance. Scand. J. Immunol. 50:420-426.
12. Sette, A., A. Vitiello, B. Reherman, P. Fowler, R. Nayersina, W.M. Kast, C.J. Melief, C. Oseroff, L. Yuan, J. Ruppert, et al. 1994. The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes. J. Immunol. 153:5586-5592.
13. Daly, K., P. Nguyen, D.L. Woodland, and M.A. Blackman. 1995. Immunodominance of major histocompatibility complex class I-restricted influenza virus epitopes can be influenced by the T-cell receptor repertoire. J. Virol. 69:7416-7422.
14. Selin, L.K., M.Y. Lin, K.A. Kraemer, D.M. Pardoll, J.P. Schneck, S.M. Varga, P.A. Santolucito, A.K. Pinto, and R.M. Welsh. 1999. Attrition of T cell memory: selective loss of LCMV epitope-specific memory CD8 T cells following infections with heterologous viruses. Immunity. 11:733-742.
15. + T-cell response is much less apparent following secondary challenge. J. Virol. 74:3486-3493.
16. Belz, G.T., W. Xie, and P.C. Doherty. 2001. Diversity of epitope and cytokine profiles for primary and secondary influenza a virus-specific CD8+ T cell responses. J. Immunol. 166:4627-4633.
17. Hou, S., P.C. Doherty, M. Zijlstra, R. Jaenisch, and J.M. Katz. 1992. Delayed clearance of Sendai virus in mice lacking class I MHC-restricted CD8+ T cells. J. Immunol. 149:1319-1325.
18. Deckhut, A.M., W. Allan, A. McMickle, M. Eichelberger, M.A. Blackman, P.C. Doherty, and D.L. Woodland. 1993. Prominent usage of V beta 8.3 T cells in the H-2Db-restricted response to an influenza A virus nucleoprotein epitope. J. Immunol. 151:2658-2666.
19. Cole, G.A., T.L. Hogg, M.A. Coppola, and D.L. Woodland. 1997. Efficient priming of CD8+ memory T cells specific for a subdominant epitope following Sendai virus infection. J. Immunol. 158:4301-4309.
20. Cole, G.A., V.K. Clements, E.P. Garcia, and S. Ostrand-Rosenberg. 1987. Allogeneic H-2 antigen expression is insufficient for tumor rejection. Proc. Natl. Acad. Sci. USA. 84:8613-8617.
21. Sanderson, S., and N. Shastri. 1994. LacZ inducible, antigen/ MHC-specific T cell hybrids. Int. Immunol. 6:369-376.
22. Dobbs, L.G., R. Gonzalez, and M.C. Williams. 1986. An improved method for isolating type II cells in high yield and purity. Am. Rev. Respir. Dis. 134:141-145.
23. Dobbs, L.G. 1990. Isolation and culture of alveolar type II cells. Am. J. Physiol. 258:L134-L147.
24. Wilson, J.S., J.A. Steinkamp, and B.E. Lehnert. 1986. Isolation of viable type II alveolar epithelial cells by flow cytometry. Cytometry. 7:157-162.
25. Altman, J.D., P.H. Moss, P.R. Goulder, D.H. Barouch, M.G. McHeyzer-Williams, J.I. Bell, A.J. McMichael, and M.M. Davis. 1996. Phenotypic analysis of antigen-specific T lymphocytes. Science. 274:94-96.
26. White, J., M. Blackman, J. Bill, J. Kappler, P. Marrack, D.P. Gold, and W. Born. 1989. Two better cell lines for making hybridomas expressing specific T cell receptors. J. Immunol. 143:1822-1825.
27. Usherwood, E.J., T.L. Hogg, and D.L. Woodland. 1999. Enumeration of antigen-presenting cells in mice infected with Sendai virus. J. Immunol. 162:3350-3355.
28. Liu, L., E. Flano, E.J. Usherwood, S. Surman, M.A. Blackman, and D.L. Woodland. 1999. Lytic cycle T cell epitopes are expressed in two distinct phases during MHV-68 infection. J. Immunol. 163:868-874.
29. Karttunen, J., and N. Shastri. 1991. Measurement of ligand-induced activation in single viable T cells using the lacZ reporter gene. Proc. Natl. Acad. Sci. USA. 88:3972-3976.
30. Lutz, M.B., N. Kukutsch, A.L. Ogilvie, S. Rossner, F. Koch, N. Romani, and G. Schuler. 1999. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J. Immunol. Methods. 223:77-92.
31. Liu, L., E.J. Usherwood, M.A. Blackman, and D.L. Woodland. 1999. T-Cell vaccination alters the course of murine herpesvirus 68 infection and the establishment of viral latency in mice. J. Virol. 73:9849-9857.
32. Chen, H.D., A.E. Fraire, I. Joris, M.A. Brehm, R.M. Welsh, and L.K. Selin. 2001. Memory CD8+ T cells in heterologous antiviral immunity and immunopathology in the lung. Nat. Immunol. 2:1067-1076.
33. Turner, S.J., R. Cross, W. Xie, and P.C. Doherty. 2001. Concurrent naive and memory CD8(+) T cell responses to an influenza A virus. J. Immunol. 167:2753-2758.
34. Massey, T.E., B.A. Geddes, and P.G. Forkert. 1987. Isolation of nonciliated bronchiolar epithelial (Clara) cells and alveolar type II cells from mouse lungs. Can. J. Physiol. Pharmacol. 65:2368-2372.
35. White, D.W., A. MacNeil, D.H. Busch, I.M. Pilip, E.G. Pamer, and J.T. Harty. 1999. Perforin-deficient CD8+ T cells: in vivo priming and antigen-specific immunity against Listeria monocytogenes. J. Immunol. 162:980-988.
36. Topham, D.J., R.A. Tripp, and P.C. Doherty. 1997. CD8+ T cells clear influenza virus by perforin or Fas-dependent processes. J. Immunol. 159:5197-5200.
37. Norbury, C.C., D. Malide, J.S. Gibbs, J.R. Bennink, and J.W. Yewdell. 2002. Visualizing priming of virus-specific CD8+ T cells by infected dendritic cells in vivo. Nat. Immunol. 3:265-271.
38. Jenkins, M.K., A. Khoruts, E. Ingulli, D.L. Mueller, S.J. McSorley, R.L. Reinhardt, A. Itano, and K.A. Pape. 2001. In vivo activation of antigen-specific CD4 T cells. Annu. Rev. Immunol. 19:23-45.
39. Hamilton-Easton, A., and M. Eichelberger. 1995. Virus-specific antigen presentation by different subsets of cells from lung and mediastinal lymph node tissues of influenza virus-infected mice. J. Virol. 69:6359-6366.
40. Webby, R.J., S. Andreansky, J. Stambas, J.E. Rehg, R.G. Webster, P.C. Doherty, and S.J. Turner. Protection and compensation in the influenza virus-specific CD8+ T cell response. Proc. Natl. Acad. Sci. USA. In press.
41. Butz, E.A., and M.J. Bevan. 1998. Differential presentation of the same MHC class I epitopes by fibroblasts and dendritic cells. J. Immunol. 160:2139-2144.
42. Nugent, C.T., J.M. McNally, R. Chervenak, R.M. Wolcott, and S.R. Jennings. 1995. Differences in the recognition of CTL epitopes during primary and secondary responses to herpes simplex virus infection in vivo. Cell. Immunol. 165:55-64.
43. Bender, A., M. Albert, A. Reddy, M. Feldman, B. Sauter, G. Kaplan, W. Hellman, and N. Bhardwaj. 1998. The distinctive features of influenza virus infection of dendritic cells. Immunobiology. 198:552-567.
44. Lopez, C.B., A. Fernandez-Sesma, S.M. Czelusniak, J.L. Schulman, and T.M. Moran. 2000. A mouse model for immunization with ex vivo virus-infected dendritic cells. Cell. Immunol. 206:107-115.
45. Heath, W.R., and F.R. Carbone. 1999. Cytotoxic T lymphocyte activation by cross-priming. Curr. Opin. Immunol. 11:314-318.
46. Budowsky, E.I., E.A. Friedman, N.V. Zheleznova, and F.S. Noskov. 1991. Principles of selective inactivation of viral genome. VI. Inactivation of the infectivity of the influenza virus by the action of beta-propiolactone. Vaccine. 9:398-402.
47. Van Kaer, L., P.G. Ashton-Rickardt, M. Eichelberger, M. Gaczynska, K. Nagashima, K.L. Rock, A.L. Goldberg, P.C. Doherty, and S. Tonegawa. 1994. Altered peptidase and viral-specific T cell response in LMP2 mutant mice. Immunity. 1:533-541.
48. + T cells at the levels of T cell repertoire and presentation of viral antigens. J. Exp. Med. 193:1319-1326.
49. Van den Eynde, B.J., and S. Morel. 2001. Differential processing of class-I-restricted epitopes by the standard proteasome and the immunoproteasome. Curr. Opin. Immunol. 13:147-153.